RecruitingPhase 4NCT06715085

PRGF-ENDORET® Infiltrations in the Treatment of Low Back Pain.

Multicenter, Randomized, Single-blind, Controlled Clinical Trial to Evaluate the Safety and Efficacy of PRGF-ENDORET® Infiltrations in the Treatment of Low Back Pain.

Sponsor

Biotechnology Institute IMASD

Enrollment

48 participants

Start Date

Jan 23, 2025

Study Type

INTERVENTIONAL

Conditions

Diseases [C] - Musculoskeletal Diseases [C05

Summary

The goal of this clinical trial is to evaluate the efficacy of PRGF in reducing pain and improving patients' quality of life. Researchers will compare an experimental drug (Plasma Rich in Growth Factors) to a control corticosteroid solution in saline solution.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Corticosteroid solution (Celestone Cronodose suspension for injection) in saline solution. and a drug called Plasma Rich in Growth Factors (PRGF) for people with diseases [c] - musculoskeletal diseases [c05. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPlasma Rich in Growth Factors (PRGF)

The PRGF application consists of three series of infiltrations in the intervertebral disc, epidural space and facets, with a frequency of two weeks.

DRUGCorticosteroid solution (Celestone Cronodose suspension for injection) in saline solution.

The corticosteroid solution application consists of two series of infiltrations of solution of corticosteroid (Celestone Cronodose injectable suspension \[betamethasone\]) and saline solution in the epidural space and in the facets, with a periodicity of one month between them.

Locations(1)

Clínica Eduardo Anitua

Vitoria-Gasteiz, Alava, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06715085